- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in Alzheimer’s disease
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume 259, Issue 2, Pages 201-211
Publisher
Springer Nature
Online
2011-06-26
DOI
10.1007/s00415-011-6145-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?
- (2017) Ana Martinez et al. JOURNAL OF ALZHEIMERS DISEASE
- Phosphorylated Tau: Toxic, Protective, or None of the Above
- (2017) Rudy J. Castellani et al. JOURNAL OF ALZHEIMERS DISEASE
- Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
- (2017) Ashley I. Bush JOURNAL OF ALZHEIMERS DISEASE
- Oxidative Stress in Diabetes and Alzheimer's Disease
- (2017) V. Prakash Reddy et al. JOURNAL OF ALZHEIMERS DISEASE
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
- (2012) Daniela Galimberti et al. CNS & Neurological Disorders-Drug Targets
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Preliminary Evidence of Validity of the Revised Criteria for Alzheimer Disease Diagnosis
- (2010) Giovanni B. Frisoni et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population
- (2010) F.H. Bouwman et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease
- (2010) Richard Dodel et al. DRUGS
- Molecular mechanisms of neurodegeneration in Alzheimer's disease
- (2010) L. Crews et al. HUMAN MOLECULAR GENETICS
- Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis
- (2010) Celeste A de Jager et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
- (2010) S. W. Pimplikar et al. JOURNAL OF NEUROSCIENCE
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Report of the task force on designing clinical trials in early (predementia) AD
- (2010) P. S. Aisen et al. NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease
- (2008) Paul S. Aisen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Therapeutic Strategies for Alzheimer’s Disease
- (2008) Donna M. Barten et al. MOLECULAR NEUROBIOLOGY
- Tau-based treatment strategies in neurodegenerative diseases
- (2008) Anja Schneider et al. Neurotherapeutics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now